LC-MS/MS method for the quantitation of cefotetan in human plasma and its application to pharmacokinetic study

Abstract

A rapid and sensitive liquid chromatography-tandem mass spectrometry(LC-MS/MS) method for the determination of cefotetan in human plasma was developed and validated. After the protein precipitation of sample with acetonitrile, the analyte and internal standard(IS), tramadol, were separated on a Zorbax XDB C₈ column using acetonitrile/1%(volume fraction) formic acid(volume ratio 35:65, pH=2.5) as mobile phase at a flow rate of 1.0 mL/min with a 1:1 split. The detection was performed by electrospray ionization with positive ion mode, followed by multiple reaction monitoring of the transitions for cefotetan at m/z 576.3→460.2(quantifier) and m/z 576.3→432.2(qualifier) and for IS at m/z 264.1→58.1. Cefotetan and IS were eluted at 1.86 and 1.87 min, respectively. The assay was linear over the concentration range of 0.1–100 μg/mL for 20 μL of human plasma only with intra- and inter-day precisions(expressed as the relative standard deviation) of less than 6.62% and accuracies(as relative error) of ±1.31%. The method was applied to the pharmacokinetic study of a 1-h intravenous infusion of 1.0 g of cefotetan disodium for human volunteers(n=6).

Keywords

Cefotetan / Liquid chromatography-tandem mass spectrometry(LC-MS/MS) / Pharmacokinetics / Human plasma

References

[1] Cho A, Lee H, Park H, Oh Y. Korean Journal of Critical Care Medicine, 2012, 27: 126.

[2] Yano K, Suzaki K, Saito M, Toda M, Naito S, Ohmi Y. Jpn. J. Antibiot., 1982, 35: 438.

[3] Gribble M. Can. Med. Assoc. J., 1994, 151: 537.

[4] Singh A, Ebenso E. International Journal of Electrochemical Science, 2013, 8: 10903.

[5] Aoyama R, Kakizaki Y, Ohnishi A, Izumi Y, Fujita M, Nagata K, Asuka N, Kudo M, Chiba C, Tsushima N. Jpn. J. Antibiot., 1983, 36: 1191.

[6] Aso K, Nakashima T, Miyachi Y, Nishikawa K, Ogawa A, Yafuso M, Kuno K. Jpn. J. Antibiot., 1983, 36: 1295.

[7] Chimura T, Morisaki N, Goto T, Inoue K, Funayama T. Jpn. J. Antibiot., 1983, 36: 2450.

[8] Maculotti L, Grassi L. Minerva. Chir., 1995, 50: 121.

[9] Chapman S J, Owen J. Am. J. Obstet. Gynecol., 1997, 177: 831.

[10] Itani K M, Wilson S E, Awad S S, Jensen E H, Finn T S, Abramson M A. New Engl. J. Med., 2006, 355: 2640.

[11] Guibert J, Kitzis M D, Yvelin C, Acar J F. J. Antimicrob. Chemother., 1983, 11(Suppl.): 201.

[12] Adam H K, Houghton H L, Yates R A. J. Antimicrob. Chemother., 1983, 11(Suppl.): 193.

[13] Pehourcq F, Jarry C. J. Chromatogr. A, 1998, 812: 159.

[14] Shi S, Liu Y, Li Z, Zheng H, Lü Y, Chen H. Clin. Ther., 2010, 32: 1832.

[15] Su M X, Liu M H, Di B, Huang L, Jiang Y, Ma P, Hang T. Eur. J. Drug Metab. Ph., 2011, 36: 223.

[16] Lin J, Zhang D, Yao S, Hu C. Sci. Sin. Chim., 2010, 40: 75.

[17] Liu Y, Huang J, Liu J, Ma L, Lü Y, Shi S. J. Huazhong U. Sci-Med., 2012, 32: 779.